Association of serum bilirubin with pulsatile arterial function in asymptomatic young adults: the Bogalusa Heart Study

Metabolism: Clinical and Experimental

Volumn 57, Issue 5, 2008, Pages 612-616

  Bhuiyan, Azad R ^a   Srinivasan, Sathanur R ^a   Chen, Wei ^a   Sultana, Aqfa ^a   Berenson, Gerald S ^a  

^a Tulane Center for Cardiovascular Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERIAL PRESSURE; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; FEMALE; HEART FUNCTION; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE WAVE; RADIAL ARTERY; RISK FACTOR;

ADOLESCENT; ADULT; ARTERIES; BILIRUBIN; CARDIOVASCULAR DISEASES; COMPLIANCE; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; OXIDATIVE STRESS;

EID: 42949118681     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.12.003     Document Type: Article

References (42)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Gibaldi M. Antioxidant vitamins and health. J Clin Pharmacol 36 (1996) 1093-1099
3. Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., and Ames B.N. Bilirubin is an antioxidant of possible physiologic importance. Science 235 (1987) 1043-1046
4. Wu T.W., Fung K.P., and Yang C.C. Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than Trolox. Life Sci 54 (1994) 477-481
5. Llesuy S.F., and Tomaro M.L. Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damage. Biochim Biophs Acta 1223 (1994) 9-14
6. Schwertner H.A., Jackson W.G., and Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 40 (1994) 18-23
7. Hopkins P.N., Wu L.L., Hunt S.C., James B.C., Vincent G.M., and Williams R.R. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol 16 (1996) 250-255
8. Ishizaka N., Ishizaka Y., Takahashi E., Yamakado M., and Hashimoto H. High serum bilirubin level is inversely associated with the presence of carotid plaque. Stroke 32 (2001) 580-583
9. Djousse L., Levy D., Cupples L.A., Evans J.C., D'Agostino R.B., and Ellison R.C. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 87 (2001) 1196-1200
10. Arnett D.K., Evans G.W., and Riley W.A. Arterial stiffness: a new cardiovascular risk factor?. Am J Epidemiol 140 (1994) 669-682
11. Safar M.E., Henry O., and Meaume S. Aortic pulse wave velocity: an independent marker of cardiovascular risk. Am J Geriatr Cardiol 11 (2002) 295-298
12. Laurent S., Boutouyrie P., Asmar R., Gautier I., Laloux B., Guize L., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37 (2001) 1236-1241
13. Gibbons G.H., and Dzau V.J. The emerging concept of vascular remodeling. N Engl J Med 330 (1994) 1431-1438
14. Cohn J.N., Finkelstein S., McVeigh G., Morgan D., LeMay L., Robinson J., et al. Noninvasive pulse wave analysis for the early detection of vascular disease. Hypertension 26 (1995) 503-508
15. McVeigh G., Brennan G., Hayes R., Cohn J., Finkelstein S., and Johnston D. Vascular abnormalities in non-insulin-dependent diabetes mellitus identified by arterial waveform analysis. Am J Med 95 (1993) 424-430
16. Blacher J., Asmar R., Djane S., London G.M., and Safar M.E. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 33 (1999) 1111-1117
17. The Bogalusa Heart Study 20th anniversary symposium. Am J Med Sci 310 suppl (1995) S1-S138
18. Srinivasan S.R., and Berenson G.S. Serum lipoproteins in children and methods for study. In: Lewis L.A. (Ed). CRC handbook of electrophoresis. v. III. Lipoprotein methodology and human studies (1983), CRC Press, Boca Raton 185-204
19. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
20. Hypertension Diagnostics Inc. HDI/Pulsewave CR-2000 Research CardioVascular Profiling System Operator's Manual (1999), Hypertension Diagnostics, Eagan (Minn)
21. Finkelstein S.M., and Cohn J.N. First- and third-order models for determining arterial compliance. J Hypertens 10 Suppl (1992) S11-S14
22. Bhuiyan A.R., Li S., Li H., Chen W., Srinivasan S.R., and Berenson G.S. Distribution and correlates of arterial compliance measures in asymptomatic young adults: the Bogalusa Heart Study. Am J Hypertens 18 (2005) 684-691
23. Puranik R., and Celermajer D.S. Smoking and endothelial function. Prog Cardiovasc Dis 45 (2003) 443-458
24. Dzau V.J. Theodore Cooper Lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 37 (2001) 1047-1052
25. Gullu H., Erdogan D., Tok D., Topcu S., Caliskan M., Ulus T., et al. High serum bilirubin concentrations preserve coronary flow reserve and coronary microvascular functions. Arterioscler Thromb Vasc Biol 25 (2005) 2289-2294
26. Erdogan D., Gullu H., Yildirim E., Tok D., Kirbas I., Ciftci O., et al. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis 184 (2006) 431-437
27. Ollinger R., Bilban M., Erat A., Froio A., McDaid J., Tyagi S., et al. Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation 112 (2005) 1030-1039
28. Kawamura K., Ishikawa K., Wada Y., Kimura S., Matsumoto H., Kohro T., et al. Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler Thromb Vasc Biol 25 (2005) 155-160
29. Vitek L., Jirsa M., Brodanova M., Kalab M., Marecek Z., Danzig V., et al. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 160 (2002) 449-456
30. Kwak J.Y., Takeshige K., Cheung B.S., and Minakami S. Bilirubin inhibits the activation of superoxide-producing NADPH oxidase in a neutrophil cell-free system. Biochem Biophys Acta 1076 (1991) 369-373
31. Hansen T.W., Mathiesen S.B., and Walaas S.I. Bilirubin has widespread inhibitory effects on protein phosphorylation. Pediatr Res 39 (1996) 1072-1077
32. Amit Y., and Boneh A. Bilirubin inhibits protein kinase C activity and protein kinase C-mediated phosphorylation of endogenous substrates in human skin fibroblasts. Clin Chem Acta 223 (1993) 103-111
33. Ambrose J.A., and Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 43 (2004) 1731-1737
34. McVeigh G.E., Morgan D.J., Finkelstein S.M., Lemay L.A., and Cohn J.N. Vascular abnormalities associated with long-term cigarette smoking identified by arterial waveform analysis. Am J Med 102 (1997) 227-231
35. Schwertner H.A. Association of smoking and low serum bilirubin antioxidant concentrations. Atherosclerosis 136 (1998) 383-387
36. Wassmann S., Wassmann K., and Nickenig G. Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension 44 (2004) 381-386
37. Facchini F.S., Hua N.W., Reaven G.M., and Stoohs R.A. Hyperinsulinemia: the missing link among oxidative stress and age-related diseases?. Free Radic Biol Med 29 (2000) 1302-1306
38. Keaney Jr. J.F., Larson M.G., Vasan R.S., Wilson P.W., Lipinska I., Corey D., et al. Framingham Study. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 23 (2003) 434-439
39. Navab M., Berliner J.A., Watson A.D., Hama S.Y., Territo M.C., Lusis A.J., et al. The yin and yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler Thromb Vasc Biol 16 (1996) 831-842
40. Li H., Srinivasan S.R., Chen W., Xu J.H., Li S., and Berenson G.S. Vascular abnormalities in asymptomatic, healthy young adult smokers without other major cardiovascular risk factors: the Bogalusa Heart Study. Am J Hypertens 18 (2005) 319-324
41. McVeigh G.E., Bratteli C.W., Morgan D.J., Alinder C.M., Glasser S.P., Finkelstein S.M., et al. Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: aging and arterial compliance. Hypertension 33 (1999) 1392-1398
42. McVeigh G.E., Allen P.B., Morgan D.R., Hanratty C.G., and Silke B. Nitric oxide modulation of blood vessel tone identified by arterial waveform analysis. Clin Sci (Lond) 100 (2001) 387-393